NYSE:EVHC - New York Stock Exchange, Inc. -
Health insurer Humana Inc. said health-care industry veteran James Rechtin will take over as its chief executive officer in the second half of 2024, when Bruce Broussard will step down from the role.
Mentions: HUM
Struggling companies like Incora and Envision Healthcare Corp. asked lenders for lifelines, and got them, in contentious transactions that sometimes triggered lawsuits. Then they went bust anyway.
Envision Healthcare Corp., one of the biggest private equity-backed medical staffing companies, reported another quarter of losses as it deals with continued pressures from the pandemic.
New debt sales from blue-chip companies are poised to reach a record for annual issuance this week as more opportunistic borrowers lock in some of the lowest borrowing costs in history. Meanwhile, high-yield supply may slow to a trickle.
There’s a saying in the junk bond market that covenants don’t matter until they do. Now, as the economic fallout from the Covid-19 pandemic sends a new class of companies spiraling into distress, those investor protections are being put to the test.
Envision Healthcare Corp. has hired restructuring advisers and is contemplating a bankruptcy filing after the Covid-19 pandemic halted elective surgeries and left the company struggling to manage the $7 billion of debt from its 2018 leveraged buyout.
Envision Healthcare Corp., one of the biggest medical providers backed by private equity, is withholding some pay for doctors and contemplating salary cuts amid the coronavirus pandemic.
Margin of Safety Calculated for NYSE:EVHC | Healthcare, News
Margin of Safety Calculated for NYSE:EVHC | Healthcare, News
Margin of Safety Calculated for NYSE:EVHC | Healthcare, News
Margin of Safety Calculated for NYSE:EVHC | Healthcare, News
Some of the names on the move ahead of the open.
EVHC – Cantor Fitzgerald reiterates Hold rating, $46 PT. This price target represents a 2.95% upside over the stock’s previous closing price of $44.68.
In a report released today, Joseph France from Cantor Fitzgerald reiterated a Hold rating on Envision Healthcare (NYSE: EVHC), with a price target of $46. The company’s shares closed yesterday at $44.68. France said: “. We are reiterating our Neutral rating, but adjusting our 2018 and 2019 estimates to reflect 2Q18 results, and raising our
EVHC – Beats Wall Street consensus EPS estimates by $0.05. Misses on revenues.
The Delivering Alpha 2018 conference took place Wednesday in New York, and this year’s event included a number of Wall Street heavy-hitters. Benzinga Pro reported live from...
Hedge fund manager Jim Chanos says he is betting that the stocks of physican practice management companies Mednax and Envision Healthcare will fall and said that private equity group KKR might get cold feet on a planned deal for Envision.
EVHC – Cautious comments from Jim Chanos at Delivering Alpha conference.
Chanos spoke at the Delivering Alpha conference in New York.
Mentions: MD
Mentions: KKR
The link between private equity and pension funds means states are inadvertently cashing in on practices they've set out to stop.
Mentions: KKR
In a report issued on June 18, Ryan Daniels from William Blair reiterated a Hold ...
The post Envision Healthcare Receives a Hold from William Blair appeared first on Smarter Analyst.